Compare
Genpact vs Maximus (G vs MMS)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Genpact (G) returned +8.9% and Maximus (MMS) -22.1%; so far this year the figures are -9.6% and -24.1%.
Genpact is the larger company by market value, about 2.1 times the size of Maximus.
On trailing earnings, G trades at 12.3 times and MMS at 9.7 times.
Revenue grew +6.7% at G and -3.3% at MMS over the last year.
G yields 1.33%. MMS yields 1.97%.
Data as of the latest close. Not investment advice.
Relative performance
| G | MMS | |
|---|---|---|
| Price | $42.27 | $65.50 |
| 1-day | +2.85% | -5.37% |
| YTD | -9.64% | -24.12% |
| 1 year | +8.89% | -22.08% |
| 3 years | +28.05% | -12.79% |
| Market cap | $7.1B | $3.4B |
| P/E | 12.3 | 9.7 |
| P/S | 1.32 | 0.65 |
| P/B | 2.61 | 1.97 |
| Revenue growth | +6.70% | -3.30% |
| EPS growth | +10.60% | +24.70% |
| Gross margin % | 36.9 | 25.6 |
| Net margin % | 11.0 | 7.1 |
| ROE % | 21.7 | 21.3 |
| Debt / equity | 0.43 | 0.94 |
| FCF yield % | 5.0 | 12.6 |
| Dividend yield % | 1.33 | 1.97 |
| Beta | 0.05 | 0.19 |
| RSI (14) | 71.1 | 59.9 |
| Technical rating |